ARCHIVES

Faulding, NaPro In Agreement For Marketing Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

House approves $210 million for Dept. of Defense cancer research programs.

June 24, 2005

Breast Cancer Task Force Hears Update on Research, Abstract Excerpter

September 19, 1980

Acupuncture Can Relieve Side Effects of Hormone Treatment

April 29, 2011

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

In Brief: David Chambers named deputy director for implementation science at NCI DCCPS

December 5, 2014

House Committee Asks Varmus About Impact of Clinical Center construction On NIH Programs

April 26, 1996